Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Free Cash Flow (2016 - 2026)

Ironwood Pharmaceuticals' Free Cash Flow history spans 16 years, with the latest figure at $74.6 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 390.18% to $74.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $127.0 million, a 22.83% increase, with the full-year FY2025 number at $127.0 million, up 22.83% from a year prior.
  • Free Cash Flow hit $74.6 million in Q4 2025 for Ironwood Pharmaceuticals, up from $47.6 million in the prior quarter.
  • Over the last five years, Free Cash Flow for IRWD hit a ceiling of $80.2 million in Q1 2023 and a floor of -$15.1 million in Q2 2025.
  • Historically, Free Cash Flow has averaged $47.4 million across 5 years, with a median of $48.1 million in 2021.
  • The widest YoY moves for Free Cash Flow: up 390.18% in 2025, down 145.11% in 2025.
  • Tracing IRWD's Free Cash Flow over 5 years: stood at $64.4 million in 2021, then grew by 22.92% to $79.2 million in 2022, then plummeted by 55.03% to $35.6 million in 2023, then tumbled by 57.29% to $15.2 million in 2024, then skyrocketed by 390.18% to $74.6 million in 2025.
  • Business Quant data shows Free Cash Flow for IRWD at $74.6 million in Q4 2025, $47.6 million in Q3 2025, and -$15.1 million in Q2 2025.